CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences. GenMark’s management is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference in a virtual setting on Tuesday, January 12th,...
Read Full StoryRelated
, 8min
0
, 10min
0